The best stock screener for US stocks in 2026 is Finviz for investors who only screen the US market — it has the deepest filter set, the fastest interface, and a free no-account tier with over 60 fundamental and technical filters. For investors who also screen European and Canadian equities alongside US stocks in a single tool, ScreenerHero covers all three markets with reliable fundamental data at a lower monthly price than Finviz Elite.
Last updated: June 2026.
What makes a good US stock screener?
The US equity market spans roughly 6,000 listed companies across NYSE, NASDAQ, and NYSE American. A good US stock screener needs to handle the full universe — not just S&P 500 components — with:
- Reliable fundamental data for small and mid-caps. Many US small caps below $500M market cap have inconsistent data in screeners that rely on a single data provider. P/E, EV/EBITDA, and margin data should be available and up to date for the full NYSE and NASDAQ universe.
- At least 30–40 fundamental filters. The minimum useful set: market cap, P/E, P/B, EV/EBITDA, revenue growth, profit margin, ROE, dividend yield, debt-to-equity, and beta. Professional-grade screeners add insider ownership, short float, institutional ownership, and earnings estimate revisions.
- Fast filter updates. Results should refresh in under two seconds. A screener that requires page reloads for each filter change is unusable for iterative screening.
- A usable free tier. The best US screeners have free tiers that don't degrade the core screening experience. Requiring an account or hiding core filters behind a paywall is a red flag.
- Technical overlays. US investors more frequently combine fundamental and technical screening than European investors. RSI, moving averages, chart patterns alongside fundamental filters are a genuine workflow requirement for many US investors.
The 7 main US stock screeners compared
1. Finviz — Best for pure US fundamental screening
Coverage: US equities only — NYSE, NASDAQ, NYSE American, OTC markets. Small number of European ADRs listed in the US. No direct coverage of European or Canadian exchanges.
Filters: 65+ filters including fundamental (P/E, P/B, EV/EBITDA, ROE, margins, debt, dividend yield), technical (RSI, moving averages, 52-week range, chart patterns), and ownership (insider ownership, institutional ownership, short float). The most comprehensive US filter set of any screener.
Free tier: Full fundamental screener, no account required. Data is 15-minute delayed on the free tier. Results include a stock table, map view, and news feed.
Paid plan: $39.50/month Elite · $299.50/year (~$25/month). Elite adds real-time data, backtesting, email alerts, and an advanced chart mode.
Best for: US equity investors whose workflow is entirely within the US market. Nothing surpasses Finviz for filtering the NYSE and NASDAQ universe by fundamental and technical criteria simultaneously.
Limitations: No European or Canadian coverage. Investors who screen across markets need a separate tool for non-US equities.
2. ScreenerHero — Best for US + European + Canadian screening in one tool
Coverage: US (NYSE, NASDAQ), Canada (TSX, TSXV), and all major European exchanges — XETRA, Euronext Paris, BME, Borsa Italiana, Euronext Amsterdam, plus alternative markets (Euronext Growth, Nasdaq First North, EGM Milan, GPW NewConnect). Coverage for US stocks is equivalent to Finviz for fundamental criteria; adds international coverage Finviz lacks entirely.
Filters: P/E, P/B, EV/EBITDA, FCF yield, ROE, ROIC, revenue growth, profit margin, dividend yield, beta, debt-to-EBITDA, market cap. All filters work reliably for US stocks at any market cap level.
Free tier: Full screener, no account required. No time limit. Pro features (watchlists, alerts, saved presets) require an account.
Paid plan: €29/month Pro (~$31/month). Less expensive than Finviz Elite at equivalent functionality for cross-market investors.
Best for: Investors who analyze US stocks alongside European or Canadian equities. Particularly useful for global value investors who compare valuations across markets and need a single consistent screener interface.
Limitations: No technical analysis filters (RSI, chart patterns). Not a charting platform — designed for fundamental screening only.
3. Stock Analysis — Best completely free US screener
Coverage: US equities — NYSE, NASDAQ, NYSE American. Good fundamental data quality for S&P 500 and Russell 2000 components. OTC coverage is lighter.
Filters: Market cap, P/E, P/S, P/B, EV/EBITDA, dividend yield, revenue growth, earnings growth, profit margin, debt-to-equity. Around 30–35 filters — sufficient for most value and growth screening workflows.
Free tier: Fully free, no account required, no filter restrictions. One of the most generous free tiers of any US screener.
Paid plan: No paid plan for the screener. The site monetizes through premium individual stock analysis reports.
Best for: Investors who want a capable US screener at zero cost without account creation. Good for straightforward fundamental screens without technical overlays.
Limitations: No technical filters. Filter depth is below Finviz. No European or Canadian coverage. OTC data can be sparse.
4. Yahoo Finance — Basic, widely used, not systematic
Coverage: US equities, plus global markets. Broad coverage but fundamental data quality for US small caps is inconsistent — particularly below $300M market cap.
Filters: Around 20 filters — market cap, P/E, P/S, EV/EBITDA, dividend yield, earnings date, 52-week price range. Filter updates require page navigation, not real-time results.
Free tier: Free with account. Core screener is usable without paying.
Paid plan: Yahoo Finance Plus at ~$25–35/month adds more data and removes ads.
Best for: Casual investors who want a starting point and are already in the Yahoo Finance ecosystem. Not suited for systematic screening or research-driven workflows.
Limitations: Slow, page-reload-based screener. Filter depth is insufficient for serious screening. Data quality for US small caps is unreliable. Better used for individual stock research than systematic filtering.
5. Zacks — Best for earnings estimate-driven screening
Coverage: US equities — NYSE, NASDAQ. Strong on earnings estimates and earnings revision tracking. Fundamental data quality is generally good for US stocks above $200M market cap.
Filters: Fundamental filters plus Zacks Rank (proprietary earnings estimate revision signal), earnings estimate revisions, earnings surprise history, analyst recommendations. The earnings-estimate layer is genuinely differentiated for investors whose strategy is estimate-driven.
Free tier: Limited. Core screener features are behind a paywall. Basic Zacks Rank lookup is free.
Paid plan: $249/year Zacks Premium ($20.75/month).
Best for: US investors whose strategy incorporates earnings estimate revisions — particularly growth-at-a-reasonable-price (GARP) and momentum investors who want a systematic earnings quality signal. The Zacks Rank has documented predictive value over 3–6 month horizons.
Limitations: No European or Canadian coverage. Not a free option for core features. UX is dated. Less useful for pure value screening where earnings estimates matter less than current fundamentals.
6. TradingView — Best for combining charts and US fundamental filters
Coverage: US equities and global markets including European and Canadian exchanges. Fundamental data for US large and mid-cap stocks is good; small cap data consistency varies.
Filters: Technical-first — RSI, moving averages, volume, chart patterns. Fundamental filters available: P/E, P/S, EV/EBITDA, market cap, dividend yield. Unique in allowing technical and fundamental criteria in one filter pass.
Free tier: Account required. Screener is restricted on the free plan — filter combinations are limited.
Paid plan: $15–60/month depending on tier.
Best for: US investors who drive decisions primarily from charts and want fundamental filters as a secondary check. If your workflow starts with a chart, not a filter table, TradingView is the natural home.
Limitations: Fundamental data for US small caps is less reliable than Finviz. Not optimized for systematic fundamental screening — the screener is secondary to charting. Requires account even for the free tier.
7. TIKR — Best for historical financial depth on US stocks
Coverage: 100,000+ stocks globally including US, Canada, and Europe. Fundamental data quality for US companies is strong, particularly for larger names with long reporting histories. Historical data going back 20 years on Pro.
Filters: Extensive fundamental filters plus 20-year historical financial data per company. Revenue, margins, earnings, FCF, and balance sheet going back two decades is a genuine differentiator for long-term fundamental investors.
Free tier: Freemium with friction. Account required. Core screener is accessible; advanced historical features require paid plan.
Paid plan: ~$10–15/month Plus · $40–55/month Pro.
Best for: Long-term investors who need deep historical financials alongside screening. Ten-year ROIC trends, margin history, and balance sheet evolution are visible for individual stocks — useful for assessing business durability.
Limitations: Not optimized for rapid filter iteration — the UX is research-focused, not screener-focused. More expensive than Finviz on the Pro tier for users who only need US coverage.
US stock screener comparison table (2026)
| Screener | US Coverage | Filter Depth | Technical Filters | Price/mo | Free No-Account |
|---|---|---|---|---|---|
| Finviz | ✓ Full | 65+ | ✓ | $39.50 | Yes |
| ScreenerHero | ✓ Full | 30+ | ✗ | €29 | Yes |
| Stock Analysis | ✓ Full | 30–35 | ✗ | Free | Yes |
| Yahoo Finance | Partial | ~20 | Limited | $25–35 | Partial |
| Zacks | ✓ Full | 30+ earnings | ✗ | $20.75 | No |
| TradingView | ✓ Full | 25+ | ✓ | $15–60 | No |
| TIKR | ✓ Full | 40+ | ✗ | $15–55 | No |
Data as of June 2026.
Which US stock screener should you use?
If you only screen US stocks and want the most filter depth: → Finviz. The deepest US fundamental screener available. Free no-account tier covers most needs; Elite ($39.50/mo) adds real-time data and alerts.
If you screen US stocks alongside European and Canadian equities: → ScreenerHero. One consistent interface across all three markets. Less expensive than Finviz Elite for cross-market investors who would otherwise need two tools.
If you want a completely free US screener: → Stock Analysis. No account, no hidden paywalls, 30+ filters that cover value and growth screening adequately.
If earnings estimates and revisions drive your strategy: → Zacks. The Zacks Rank is the most documented systematic earnings revision signal available to retail investors. Worth the ~$20/month for estimate-driven GARP strategies.
If charts are your primary decision tool: → TradingView. The only screener that meaningfully integrates technical signals (RSI, chart patterns, moving averages) with fundamental filters in one pass.
If you need 20-year historical financials per company: → TIKR Pro. Historical depth is genuinely better than any other option for long-term fundamental investors.
How to run a basic US value screen
A practical starting point for a quality US equity screen across NYSE and NASDAQ:
Step 1 — Set a market cap floor. $300M eliminates most micro-cap names that have illiquidity risk and inconsistent data. $500M provides a more liquid starting universe.
Step 2 — Filter for profitability. Net profit margin > 0% eliminates pre-revenue and loss-making companies. For a stricter quality filter: operating margin > 8%.
Step 3 — Apply a valuation filter. P/E below 20 and EV/EBITDA below 12 are reasonable starting thresholds for a broad US value screen. Adjust by sector — utilities and financials trade on different multiples than industrials and consumer discretionary.
Step 4 — Add a quality filter. ROE above 12% identifies businesses that generate meaningful returns on shareholders' equity. Combine with debt-to-equity below 1.0 to avoid leveraged ROE from financial engineering.
Step 5 — Sort and review. Sort by EV/EBITDA ascending to surface the cheapest names meeting your quality criteria. A typical US screen on these criteria returns 80–150 companies — a workable starting list.
Frequently asked questions
What is the best free stock screener for US stocks?
Finviz (free tier) and Stock Analysis are the best free US stock screeners in 2026. Finviz requires no account and provides 65+ filters with 15-minute delayed data. Stock Analysis is fully free with 30–35 filters and no account required. Both cover the full NYSE and NASDAQ universe.
Is Finviz the best US stock screener?
For pure US fundamental screening, yes — Finviz is the industry benchmark. The filter depth (65+ filters including insider ownership, short interest, and chart patterns) is unmatched for US equities. For investors who also need European or Canadian coverage, ScreenerHero is a better fit.
What stock screener do professional US investors use?
Professional investors typically use Bloomberg Terminal or FactSet — both are institutional tools costing $20,000+/year. Among retail-accessible screeners, Finviz Elite and TIKR Pro are the closest to institutional functionality at reasonable price points.
Can I screen US and European stocks in the same tool?
Yes — ScreenerHero covers US (NYSE, NASDAQ), Canada (TSX, TSXV), and all major European exchanges in a single screener with consistent filter criteria. TradingView also covers multiple markets but is optimized for charting rather than systematic fundamental screening.
Does Finviz cover international stocks?
No. Finviz covers US equities (NYSE, NASDAQ, OTC) and a small number of European ADRs listed in the US. It does not cover European or Canadian exchanges directly. For international screening, use ScreenerHero or TradingView.
What is the cheapest stock screener for US stocks?
Stock Analysis is completely free with no account required and covers most value and growth screening needs for US stocks. Finviz's free tier is also no-account and covers professional-grade filtering with 15-minute delayed data. Among paid options, ScreenerHero at €29/month covers US, Canada, and Europe — less expensive than Finviz Elite at $39.50/month for investors who need multi-market access.
Related guides
- Finviz Alternative for European Stocks — full comparison of Finviz vs. European screeners
- Best Stock Screener for Value Investors — value-specific filter guide for US and European stocks
- How to Find Undervalued Stocks — step-by-step process from screening to investment decision
- Free Stock Screener Guide — complete breakdown of free stock screening tools
- TradingView vs Finviz — head-to-head comparison for US stock screening
Open the US stock screener → — free, no account required. Covers NYSE, NASDAQ, and 20+ European exchanges. Pro at €29/month.